DANIEL UBA: Open Payments
NPI 1578540860 · FAYETTEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,073 in 122 payments from 23 companies in 2025. Trend: 2023 $4,791 · 2024 $3,045 · 2025 $2,073
Food & beverage: $2,073
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 20 | $299 |
| Novo Nordisk Inc | 17 | $284 |
| AstraZeneca Pharmaceuticals LP | 12 | $209 |
| GlaxoSmithKline, LLC. | 16 | $181 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $136 |
| PFIZER INC. | 6 | $134 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $98 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $83 |
| Inspire Medical Systems, Inc. | 4 | $82 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $80 |
Products named: JARDIANCE, Ozempic, TRELEGY ELLIPTA, FARXIGA, Kerendia, MOUNJARO, XIFAXAN, PREVNAR 20.
Industry payments across NC — which companies pay providers there.
